SAN JOSE, CA, January 10, 2019 – MGI, a subsidiary of global genomics leader BGI Group, announced WeGene as its first early access customer for the new ultra high-throughput sequencer, MGISEQ-T7.
News Center
Updates on MGI's developments in products.
Location：
Home /
News Center
MGI J.P. Morgan Healthcare Conference Highlights
Release date：2019-01-11Writer：MGI
Recommended News
1Interview | Brock Peters: Working Hard to Enable "Perfect Genome" Sequencing2MGI's "life science super computer" DNBSEQ-T7 officially delivered to business partners3New Emergency Detection Laboratory Run by BGI Starts Trial Operation in Wuhan, Designed to Test 10,000 Samples Daily4BGI Group Supports France to Secure Equipment for Two Million COVID-19 Tests5Sinai Health Receives Key COVID-19 Testing Equipment Honouring Internationally Renowned Canadian Physician Dr. Norman Bethune6BGI Partners with Minderoo to Launch Huo-Yan Laboratory Solution to Expedite Australia-wide COVID-19 Testing
Latest Cases
